Manufacturer:
Johnson & Johnson
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
phone:
866-228-3546
Approved Indication:
treatment of pulmonary arterial hypertension (PAH, WHO group 1) in adults to reduce the risks of disease progression and hospitalization
Conditions:
- Pulmonary Arterial Hypertension